I am a senior researcher in health technology assessment (HTA) at the Maastricht University Medical Centre+, Netherlands, and an associate editor for Value in Health. I obtained my PhD at the University of Sheffield, United Kingdom, in September 2016.

In my research, I work on methods for health economic modelling, with a special interest in personalised treatment and prevention, uncertainty assessment and using value of information (VOI) analysis to support decision-making. I act as health economic lead for an External Assessment Group for the England & Wales National Institute for Health and Care Excellence (NICE) and it is important to me to connect my research with policy. In the context of HTA, I see 3 uses for VOI: 1) for risk assessment, 2) for sensitivity analysis, 3) for evaluating ongoing or new research, each requiring different VOI metrics resulting in different levels of complexity. I study barriers and facilitators to VOI analysis in these three uses within different HTA settings as well as methods for communicating VOI results. In the context of developing and validating AI decision-support, VOI analysis can be used for determining the need for further external validation using decision curve analysis and I work on guidance to define whether and when this is preferred over full economic evaluation.